Development and Validation of the Migraine‐Specific Quality of Life Questionnaire

Linking Clinical Variables With Health-Related Quality of Life: A Conceptual Model of Patient Outcomes

Wilson, I. B. (1995) · JAMA · doi:10.1001/jama.1995.03520250075037 · Cited by 3,027

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Juniper, E. F., Guyatt, G. H., Epstein, R. S., Ferrie, P. J., Jaeschke, R., & Hiller, T. K. (1992) · Thorax · doi:10.1136/thx.47.2.76 · Cited by 1,235

Measuring disease-specific quality of life in clinical trials.

Guyatt, G. H., Bombardier, C., & Tugwell, P. (1986) · Europe PMC (PubMed Central) · Cited by 728

Impact of Migraine in the United States: Data from the National Health Interview Survey

Stang, P., & Osterhaus, J. T. (1993) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1993.hed3301029.x · Cited by 335

Measuring the Functional Status and Well‐Being of Patients with Migraine Headache

Osterhaus, J. T., Townsend, R. J., Gandek, B., & Ware, J. E. (1994) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1994.hed3406337.x · Cited by 325

Quality of Life and Well-Being of Headache Patients: Measurement by the Medical Outcomes Study Instrument

Solomon, G. D., Skobieranda, F. G., & Gragg, L. A. (1993) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1993.hed3307351.x · Cited by 163

Quality of Life Assessment Among Migraine Patients Treated With Sumatriptan

Solomon, G. D., Skobieranda, F. G., & Genzen, J. R. (1995) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1995.hed3508449.x · Cited by 66

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

Aurora, S. K., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R. B., Diener, H., & Brin, M. F. (2010) · Cephalalgia · doi:10.1177/0333102410364676 · Cited by 1,056

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H., & Brin, M. F. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01678.x · Cited by 1,006

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

Diener, H., Dodick, D., Aurora, S. K., Turkel, C., DeGryse, R., Lipton, R. B., Silberstein, S., & Brin, M. F. (2010) · Cephalalgia · doi:10.1177/0333102410364677 · Cited by 974

A self-administered screener for migraine in primary care

Lipton, R. B., Dodick, D. W., D, R. S. M., Kolodner, K., Endicott, J., Hettiarachchi, J., & Harrison, W. (2003) · Neurology · doi:10.1212/01.wnl.0000078940.53438.83 · Cited by 604

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

Dodick, D. W., Ashina, M., Brandes, J. L., Kudrow, D., Lantéri‐Minet, M., Osipova, V. В., Palmer, K., Picard, H., Mikol, D. D., & Lenz, R. A. (2018) · Cephalalgia · doi:10.1177/0333102418759786 · Cited by 573

Galcanezumab in chronic migraine

Detke, H. C., Goadsby, P. J., Wang, S., Friedman, D. I., Selzler, K. J., & Aurora, S. K. (2018) · Neurology · doi:10.1212/wnl.0000000000006640 · Cited by 566

Handbook of multimethod measurement in psychology.

Eid, M., & Diener, E. (2006) · American Psychological Association eBooks · doi:10.1037/11383-000 · Cited by 497

Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators

Tfelt‐Hansen, P. C., Pascual, J., Ramadan, N. M., Dahlöf, C. G. H., D’Amico, D., Diener, H.-C., Hansen, J. M., Lantéri‐Minet, M., Loder, E., McCrory, D. C., et al. (2012) · Cephalalgia · doi:10.1177/0333102411417901 · Cited by 365

Validity and Reliability of the Migraine‐Specific Quality of Life Questionnaire (MSQ Version 2.1)

Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., & Jhingran, P. (2000) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00030.x · Cited by 299

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

Mulleners, W. M., Kim, B., Láinez, M. J. A., Lantéri‐Minet, M., Pozo‐Rosich, P., Wang, S., Tockhorn‐Heidenreich, A., Aurora, S. K., Nichols, R., Yunes‐Medina, L., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30279-9 · Cited by 274

Response to Hays et al and McHorney and Cohen: Practical Implications of Item Response Theory and Computerized Adaptive Testing

Ware, J. E., Bjorner, J. B., & Kosinski, M. R. (2000) · Medical Care · doi:10.1097/00005650-200009002-00011 · Cited by 240

Erenumab in chronic migraine with medication overuse

Tepper, S. J., Diener, H., Ashina, M., Brandes, J. L., Friedman, D. I., Reuter, U., Cheng, S., Nilsen, J., Leonardi, D. K., Lenz, R. A., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007497 · Cited by 219

Quality of life in primary headache disorders: A review

Bakar, N. A., Tanprawate, S., Lambru, G., Torkamani, M., Jahanshahi, M., & Matharu, M. S. (2015) · Cephalalgia · doi:10.1177/0333102415580099 · Cited by 217

Naratriptan as Short‐Term Prophylaxis of Menstrually Associated Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Study

Newman, L. C., Mannix, L. K., Landy, S. H., Silberstein, S., Lipton, R. B., Putnam, D. G., Watson, C. B., Jöbsis, M. M., Batenhorst, A. S., & O’Quinn, S. (2001) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.111006248.x · Cited by 179

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial

Ashina, M., Goadsby, P. J., Reuter, U., Silberstein, S. D., Dodick, D. W., Xue, F., Zhang, F., Lima, G. P. D. S., Cheng, S., & Mikol, D. D. (2021) · European Journal of Neurology · doi:10.1111/ene.14715 · Cited by 186

Applications of computerized adaptive testing (CAT) to the assessment of headache impact

Ware, J. E., Kosinski, M. R., Bjørner, J. B., Bayliss, M. S., Batenhorst, A. S., Dahlöf, C. G. H., Tepper, S. J., & Dowson, A. J. (2003) · Quality of Life Research · doi:10.1023/a:1026115230284 · Cited by 173

Acupuncture for migraine prophylaxis: a randomized controlled trial

Li, Y., Zheng, H., Witt, C. M., Roll, S., Yu, S., Yan, J., Sun, G., Zhao, L., Huang, W., Chang, X.-R., et al. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110551 · Cited by 169

Validating Migraine‐Specific Quality of Life Questionnaire v2.1 in Episodic and Chronic Migraine

Bagley, C. L., Rendas‐Baum, R., Maglinte, G. A., Yang, M. S., Varon, S. F., Lee, J., & Kosinski, M. R. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01997.x · Cited by 167

Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine

Rendas‐Baum, R., Yang, M. S., Varon, S. F., Bloudek, L. M., DeGryse, R. E., & Kosinski, M. R. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0117-0 · Cited by 165

Topiramate versus amitriptyline in migraine prevention: A 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs

Dodick, D. W., Freitag, F. G., Banks, J., Saper, J. R., Xiang, J. X., Rupnow, M. F. T., Biondi, D. M., Greenberg, S. J., & Hulihan, J. F. (2009) · Clinical Therapeutics · doi:10.1016/j.clinthera.2009.03.020 · Cited by 151

A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine

Camporeale, A., Kudrow, D., Sides, R., Wang, S., Dycke, A. V., Selzler, K. J., & Stauffer, V. L. (2018) · BMC Neurology · doi:10.1186/s12883-018-1193-2 · Cited by 138

Topiramate Treatment of Chronic Migraine: A Randomized, Placebo‐Controlled Trial of Quality of Life and Other Efficacy Measures

Silberstein, S. D., Lipton, R. B., Dodick, D. W., Freitag, F. G., Mathew, N. T., Brandes, J. L., BIGAL, M. E., Ascher, S., Morein, J., Wright, P., et al. (2009) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01508.x · Cited by 135

Erenumab (AMG 334) in episodic migraine

Ashina, M., Dodick, D. W., Goadsby, P. J., Reuter, U., Silberstein, S. D., Zhang, F., Gage, J. R., Cheng, S., Mikol, D. D., & Lenz, R. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004391 · Cited by 132

Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience

Russo, A., Silvestro, M., di Clemente, F. S., Trojsi, F., Bisecco, A., Bonavita, S., Tessitore, A., & Tedeschi, G. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01143-0 · Cited by 131

Evaluation of the Impact of Migraine and Episodic Tension‐type Headache on the Quality of Life and Performance of a University Student Population

BIGAL, M. E., Bigal, J. M., Betti, M. C. M., Bordini, C. A., & Speciali, J. G. (2001) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007710.x · Cited by 131

The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients

Rendas‐Baum, R., Bloudek, L. M., Maglinte, G. A., & Varon, S. F. (2012) · Quality of Life Research · doi:10.1007/s11136-012-0230-7 · Cited by 121

Erenumab in chronic migraine

Lipton, R. B., Tepper, S. J., Reuter, U., Silberstein, S. D., Stewart, W. F., Nilsen, J., Leonardi, D. K., Desai, P., Cheng, S., Mikol, D. D., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007452 · Cited by 115

The Utility of Home-Practice in Mindfulness-Based Group Interventions: A Systematic Review

Lloyd, A., White, R. G., Eames, C., & Crane, R. S. (2017) · Mindfulness · doi:10.1007/s12671-017-0813-z · Cited by 126

Impact of Inflammatory Bowel Disease on Health-Related Quality of Life

Casellas, F., López-Vivancos, J., Vergara, M., & Malagelada, J. (1999) · Digestive Diseases · doi:10.1159/000016938 · Cited by 111

Assessment and psychological management of recurrent headache disorders.

Holroyd, K. A. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.70.3.656 · Cited by 109

Changes in Resource Use and Outcomes for Patients With Migraine Treated With Sumatriptan

Lofland, J. H., Johnson, N. E., Batenhorst, A. S., & Nash, D. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.8.857 · Cited by 107

MSQ: Migraine-Specific Quality-of-Life Questionnaire

Jhingran, P. M., Thomas, S., LaVange, L. M., Miller, D. W., & Helms, R. W. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813060-00007 · Cited by 99

Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment

Cole, J. C., Lin, P. L., & Rupnow, M. F. T. (2007) · Quality of Life Research · doi:10.1007/s11136-007-9217-1 · Cited by 101

Use of the headache impact test (HIT‐6) in general practice: relationship with quality of life and severity

Nachit‐Ouinekh, F., Dartigues, J., Henry, P., Becg, J. ‐., Chastan, G., Lemaire, N., & Hasnaoui, A. E. (2005) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00934.x · Cited by 98

Content Validity of HIT‐6 as a Measure of Headache Impact in People With Migraine: A Narrative Review

Houts, C. R., Wirth, R. J., McGinley, J. S., Gwaltney, C. J., Kassel, E., Snapinn, S. M., & Cady, R. K. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13701 · Cited by 105

Identifying Natural Subgroups of Migraine Based on Comorbidity and Concomitant Condition Profiles: Results of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study

Lipton, R. B., Fanning, K. M., Buse, D. C., Martin, V. T., Reed, M. L., Adams, A. M., & Goadsby, P. J. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13342 · Cited by 94

Recognition and Management of Migraine in Primary Care: Influence of Functional Impact Measured by the Headache Impact Test (HIT)

Diego, E. V. D., & Lantéri‐Minet, M. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00820.x · Cited by 93

Migraine-Related Stigma and Its Relationship to Disability, Interictal Burden, and Quality of Life

Shapiro, R. E., Nicholson, R. A., Seng, E. K., Buse, D. C., Reed, M. L., Zagar, A. J., Ashina, S., Muenzel, E. J., Hutchinson, S. L., Pearlman, E. M., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000208074 · Cited by 96

placebo-controlled phase of the PREEMPT 2 trial OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized,

Diener, H., Dodick, D., Aurora, S. K., Turkel, C., Lipton, R. B., Silberstein, S., & Brin, M. F. (2011) · Cited by 92

Quality of Life in Migraine Patients: A Qualitative Study

de Velasco, I. R., González, N., Etxeberria, Y., & Jc, G.-M. (2003) · Cephalalgia · doi:10.1046/j.1468-2982.2003.00599.x · Cited by 91

Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches

Mannix, S., Skalicky, A. M., Buse, D. C., Desai, P., Sapra, S. J., Ortmeier, B. G., Widnell, K. L., & Hareendran, A. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0542-3 · Cited by 88

Botulinum Toxin Type‐A (BOTOX ® ) in the Treatment of Occipital Neuralgia: A Pilot Study

Taylor, M., Silva, S., & Cottrell, C. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01089.x · Cited by 89

OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program

Lipton, R. B., Rosen, N. L., Ailani, J., DeGryse, R. E., Gillard, P. J., & Varon, S. F. (2016) · Cephalalgia · doi:10.1177/0333102416652092 · Cited by 85

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab

Buse, D. C., Lipton, R. B., Hallström, Y., Reuter, U., Tepper, S. J., Zhang, F., Sapra, S. J., Picard, H., Mikol, D. D., & Lenz, R. A. (2018) · Cephalalgia · doi:10.1177/0333102418789072 · Cited by 91

Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)

Lipton, R. B., Serrano, D., Buse, D. C., Pavlovic, J. M., Blumenfeld, A. M., Dodick, D. W., Aurora, S. K., Becker, W. J., Diener, H., Wang, S., et al. (2015) · Cephalalgia · doi:10.1177/0333102415583982 · Cited by 86

Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine

Seng, E. K., & Holroyd, K. A. (2010) · Annals of Behavioral Medicine · doi:10.1007/s12160-010-9223-3 · Cited by 76

Migraine education improves quality of life in a primary care setting

Smith, T. R., Nicholson, R. A., & Banks, J. W. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01618.x · Cited by 73

The International Burden of Migraine Study (IBMS): Study design, methodology, and baseline cohort characteristics

Payne, K. A., Varon, S. F., Kawata, A. K., Yeomans, K., Wilcox, T. K., Manack, A., Buse, D. C., Lipton, R. B., Goadsby, P. J., & Blumenfeld, A. M. (2011) · Cephalalgia · doi:10.1177/0333102411410610 · Cited by 74

Assessing the quality of life—reality or impossible dream?

Holmes, S. (2004) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2004.06.014 · Cited by 72

Gesundheitsbezogene Lebensqualit�t bei Patienten mit chronischen Schmerzen

Gerbershagen, H. U., Lindena, G., Korb, J., & Kramer, S. (2002) · Der Schmerz · doi:10.1007/s00482-002-0164-z · Cited by 91

A global real-world assessment of the impact on health-related quality of life and work productivity of migraine in patients with insufficient versus good response to triptan medication

Lombard, L., Farrar, M., Ye, W., Kim, Y., Cotton, S. E., Buchanan, A. S., Jackson, J., & Joshi, S. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01110-9 · Cited by 69

The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK

Batty, A. J., Hansen, R. N., Bloudek, L. M., Varon, S. F., Hayward, E., Pennington, B., Lipton, R. B., & Sullivan, S. D. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.802694 · Cited by 66

Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting

Kollewe, K., Escher, C. M., Wulff, D. U., Fathi, D., Paracka, L., Mohammadi, B., Karst, M., & Dressler, D. W. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1539-0 · Cited by 63

Quality of Life in Young Italian Patients With Primary Headache

Nodari, E., Battistella, P., Naccarella, C., & Vidi, M. (2002) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2002.02079.x · Cited by 64

Systematic review of outcomes and endpoints in acute migraine clinical trials

Houts, C. R., McGinley, J. S., Nishida, T. K., Buse, D. C., Wirth, R. J., Dodick, D. W., Goadsby, P. J., & Lipton, R. B. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14067 · Cited by 66

Systematic review of outcomes and endpoints in preventive migraine clinical trials

McGinley, J. S., Houts, C. R., Nishida, T. K., Buse, D. C., Lipton, R. B., Goadsby, P. J., Dodick, D. W., & Wirth, R. J. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14069 · Cited by 63

Perceived stress in patients with migraine: a case-control study

Moon, H., Seo, J.-G., & Park, S.-P. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0780-8 · Cited by 61

Impact of Headache on Quality of Life in a General Population Survey in France (GRIM2000 Study)

Duru, G., Auray, J., Gaudin, A.-F., Dartigues, J., Henry, P., Lantéri‐Minet, M., Lucas, C., Pradalier, A., Chazot, G., & Hasnaoui, A. E. (2004) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2004.446005.x · Cited by 61

Reliability and Validity of the Migraine Disability Assessment Scale among Migraine and Tension Type Headache in Iranian Patients

Zandifar, A., Asgari, F., Haghdoost, F., Masjedi, S. S., Manouchehri, N., Banihashemi, M., Ghorbani, A., Najafi, M. R., Saadatnia, M., & Lipton, R. B. (2014) · BioMed Research International · doi:10.1155/2014/978064 · Cited by 56

Topiramate Improves Health‐Related Quality of Life When Used to Prevent Migraine

Diamond, M. L., Dahlöf, C. G. H., Papadopoulos, G., Neto, W., & S‐C, W. (2005) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.05183.x · Cited by 56

Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life

Lipton, R. B., BIGAL, M. E., & Stewart, W. F. (2005) · Neurology · doi:10.1212/wnl.65.12_suppl_4.s50 · Cited by 55

Anxiety, Stress and Coping Behaviours in Primary Care Migraine Patients: Results of the SMILE Study

Radat, F., Mekiès, C., Géraud, G., Valade, D., Vivès, E., Lucas, C., Joubert, J.-M., & Lantéri‐Minet, M. (2008) · Cephalalgia · doi:10.1111/j.1468-2982.2008.01644.x · Cited by 53

Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a delphi study

Luedtke, K., Basener, A., Bedei, S., Castien, R., Chaibi, A., Falla, D., Fernández-de-las-Peñas, C., Gustafsson, M., Hall, T., Jull, G., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-029855 · Cited by 52

Evaluating Migraine Disability: The Headache Impact Test Instrument in Context

Pryse-Phillips, W. E. M. (2002) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100001888 · Cited by 52

Sumatriptan treatment for migraine in a health maintenance organization: Economic, humanistic, and clinical outcomes

Cohen, J. A., Beall, D. G., Beck, A. L., Rawlings, J. E., Miller, D. W., Clements, B., Pait, D. G., & Batenhorst, A. S. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88278-8 · Cited by 51

The feasibility of applying item response theory to measures of migraine impact: A re-analysis of three clinical studies

Bjorner, J. B., Kosinski, M. R., & Ware, J. E. (2003) · Quality of Life Research · doi:10.1023/a:1026175112538 · Cited by 50

In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study

Alpuente, A., Gallardo, V. J., Caronna, E., Torres‐Ferrús, M., & Pozo‐Rosich, P. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01366-9 · Cited by 47

Mapping from Disease-Specific Measures to Health-State Utility Values in Individuals with Migraine

Gillard, P. J., Devine, B., Varon, S. F., Liu, L., & Sullivan, S. D. (2012) · Value in Health · doi:10.1016/j.jval.2011.12.007 · Cited by 47

Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial

Schwedt, T. J., Oakes, T. M. M., Martinez, J. M., Vargas, B. B., Pandey, H., Pearlman, E. M., Richardson, D. R., Varnado, O. J., Meyer, M. C., & Goadsby, P. J. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00562-w · Cited by 45

Efficacy and safety of galcanezumab for prevention of migraine headache in Japanese patients with episodic migraine: A phase 2 randomized controlled clinical trial

Sakai, F., Ozeki, A., & Skljarevski, V. (2020) · Cephalalgia Reports · doi:10.1177/2515816320932573 · Cited by 45

Behavioral Migraine Management Modifies Behavioral and Cognitive Coping in People With Migraine

Seng, E. K., & Holroyd, K. A. (2014) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12426 · Cited by 44

Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)

Johnston, K., Harris, L. A., Powell, L. C., Popoff, E., Coric, V., L'Italien, G. J., & Schreiber, C. P. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01378-5 · Cited by 44

Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial

Seng, E. K., & Holroyd, K. A. (2012) · Cephalalgia · doi:10.1177/0333102411436333 · Cited by 44

The development and validation of the Cluster Headache Quality of life scale (CHQ)

Bakar, N. A., Torkamani, M., Tanprawate, S., Lambru, G., Matharu, M. S., & Jahanshahi, M. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0674-1 · Cited by 44

Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary

Kawata, A. K., Hsieh, R., Bender, R. H., Shaffer, S., Revicki, D. A., Bayliss, M. S., Buse, D. C., Desai, P., Sapra, S. J., Ortmeier, B. G., et al. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13162 · Cited by 44

Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study

Pozo‐Rosich, P., Detke, H. C., Wang, S., Doležil, D., Li, L. Q., Aurora, S. K., & Reuter, U. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2059975 · Cited by 43

Health-Related and Condition-Specific Quality of Life in Episodic Cluster Headache

Ertsey, C., Manhalter, N., Bozsik, G., Áfra, J., & Jelencsik, I. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2003.00655.x · Cited by 43

The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials

Dahlöf, C. G. H., Loder, E., Diamond, M. L., Rupnow, M. F. T., Papadopoulos, G., & Mao, L. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-56 · Cited by 43

Depression and disability in migraine: the role of pain acceptance and values-based action

Dindo, L., Recober, A., Marchman, J., O’Hara, M., & Turvey, C. (2015) · International Journal of Behavioral Medicine · doi:10.1007/s12529-014-9390-x · Cited by 41

Development and Validation of the Headache Needs Assessment (HANA) Survey

Cramer, J. A., Silberstein, S. D., & Winner, P. K. (2001) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.111006402.x · Cited by 42

Disability and quality of life in headache: where we are now and where we are heading

D’Amico, D., Grazzi, L., Usai, S., Leonardi, M., & Raggi, A. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1378-9 · Cited by 41

Do psychiatric comorbidities influence headache treatment outcomes? Results of a naturalistic longitudinal treatment study

Heckman, B. D., Holroyd, K. A., Himawan, L. K., O’Donnell, F., Tietjen, G. E., Utley, C., & Stillman, M. J. (2009) · Pain · doi:10.1016/j.pain.2009.06.019 · Cited by 39

Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience

Silvestro, M., Tessitore, A., Orologio, I., Micco, R. D., Tartaglione, L., Trojsi, F., Tedeschi, G., & Russo, A. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01436-6 · Cited by 40

Treatment of migraine with targeted nutrition focused on improved assimilation and elimination.

Sensenig, J., Johnson, M., & Staverosky, T. (2001) · PubMed · Cited by 39

Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study

Pascual, J., Panni, T., Dell’Agnello, G., Gonderten, S., Novick, D., & Evers, S. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01623-z · Cited by 39

Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial

Icco, R. D., Putortì, A., Paoli, I. D., Ferrara, E., Cremascoli, R., Terzaghi, M., Toscano, G., Allena, M., Martinelli, D., Cosentino, G., et al. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.10.014 · Cited by 37

Assessing the Value of Laser in situ Keratomileusis by Patient-reported Outcomes Using Quality of Life Assessment

Lee, J.-H., Lee, J., Park, K., Cho, W., Kim, J. Y., & Kang, H.-Y. (2005) · Journal of Refractive Surgery · doi:10.3928/1081-597x-20050101-12 · Cited by 37

The impact of migraine on daily activities: effect of topiramate compared with placebo

Silberstein, S. D., Loder, E., Forde, G., Papadopoulos, G., Fairclough, D. L., & Greenberg, S. J. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x104731 · Cited by 36

The use of clinical scales and PROMs in headache disorders and migraine, summarizing their dissemination and operationalization

Dikmen, P. Y., Özge, A., & Martelletti, P. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16187 · Cited by 40

The Psychometric Properties of the Persian Migraine‐Specific Quality of Life Questionnaire Version 2.1 in Episodic and Chronic Migraines

Zandifar, A., Masjedi, S. S., Haghdoost, F., Asgari, F., Manouchehri, N., Banihashemi, M., Najafi, M. R., Ghorbani, A., Zolfaghari, B., Gholamrezaei, A., et al. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/950245 · Cited by 35

Assessing the Ability of Topiramate to Improve the Daily Activities of Patients With Migraine

Brandes, J. L., Kudrow, D., Rothrock, J. F., Rupnow, M. F. T., Fairclough, D. L., & Greenberg, S. J. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.10.1311 · Cited by 35

Two randomized migraine studies of galcanezumab

Ford, J. H., Ayer, D. W., Zhang, Q., Carter, J. N., Leroux, É., Skljarevski, V., Aurora, S. K., Tockhorn‐Heidenreich, A., & Lipton, R. B. (2019) · Neurology · doi:10.1212/wnl.0000000000007856 · Cited by 34

Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ)

Kawata, A. K., Hareendran, A., Shaffer, S., Mannix, S., Thach, A., Desai, P., Mikol, D. D., Ortmeier, B. G., Bayliss, M. S., & Buse, D. C. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13569 · Cited by 33

Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies

Smitherman, T. A., Tietjen, G. E., Schuh, K. J., Skljarevski, V., Lipsius, S., D’Souza, D. N., & Pearlman, E. M. (2020) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13970 · Cited by 34

Patients With Migraine Have Substantial Reductions in Measures of Visual Quality of Life

Hanson, L. L., Ahmed, Z. A., Katz, B. J., Warner, J. E. A., Crum, A. V., Zhang, Y., Zhang, Y., Baggaley, S. K., Pippitt, K. A., Cortez, M. M., et al. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13330 · Cited by 33

Psychometric validation and meaningful within‐patient change of the Migraine‐Specific Quality of Life questionnaire version 2.1 electronic patient‐reported outcome in patients with episodic and chronic migraine

Speck, R. M., Yu, R., Ford, J. H., Ayer, D. W., Bhandari, R., & Wyrwich, K. W. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14031 · Cited by 33

Non-pharmacological interventions for prophylaxis of vestibular migraine

Webster, K. E., Dor, A., Galbraith, K., Kassem, L. H., Harrington-Benton, N. A., Judd, O., Kaski, D. N., Maarsingh, O. R., MacKeith, S. A. C., Ray, J., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015321.pub2 · Cited by 34

Significance of fatigue in patients with migraine

Seo, J.-G., & Park, S.-P. (2018) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2018.01.032 · Cited by 36

Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes – The Migraine Functional Impact Questionnaire (MFIQ)

Hareendran, A., Skalicky, A. M., Mannix, S., Lavoie, S., Desai, P., Bayliss, M. S., Thach, A., Mikol, D. D., & Buse, D. C. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13420 · Cited by 32

Changes in brain connectivity linked to multisensory processing of pain modulation in migraine with acupuncture treatment

Liu, L., Lyu, T., Fu, M.-Y., Wang, L., Chen, Y., Hong, J., Chen, Q.-Y., Zhu, Y., Tan, Z., Liu, D., et al. (2022) · NeuroImage Clinical · doi:10.1016/j.nicl.2022.103168 · Cited by 33

A New Instrument to Assess the Long‐term Quality of Life Effects From Migraine: Development and Psychometric Testing of the MSQOL

Wagner, T. H., Patrick, D. L., Galer, B. S., & Berzon, R. A. (1996) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1996.3608484.x · Cited by 93

Development of a Brief 24‐Hour Migraine‐Specific Quality of Life Questionnaire

Hartmaier, S. L., Santanello, N. C., Epstein, R. S., & Silberstein, S. D. (1995) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1995.hed3506320.x · Cited by 79

Validity and Reliability of the Migraine‐Specific Quality of Life Questionnaire (MSQ Version 2.1)

Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., & Jhingran, P. (2000) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2000.00030.x · Cited by 299

Validation of a New Quality of Life Questionnaire for Acute Migraine Headache

Santanello, N. C., Hartmaier, S. L., Epstein, R. S., & Silberstein, S. D. (1995) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1995.hed3506330.x · Cited by 83

Validation of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ v. 2.1) for patients undergoing prophylactic migraine treatment

Cole, J. C., Lin, P. L., & Rupnow, M. F. T. (2007) · Quality of Life Research · doi:10.1007/s11136-007-9217-1 · Cited by 101